These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1995798)

  • 1. Blood cell proliferation response to beryllium: analysis by receiver-operating characteristics.
    Stokes RF; Rossman MD
    J Occup Med; 1991 Jan; 33(1):23-8. PubMed ID: 1995798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease.
    Rossman MD; Kern JA; Elias JA; Cullen MR; Epstein PE; Preuss OP; Markham TN; Daniele RP
    Ann Intern Med; 1988 May; 108(5):687-93. PubMed ID: 3282464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
    Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neopterin in chronic beryllium disease.
    Harris J; Bartelson BB; Barker E; Balkissoon R; Kreiss K; Newman LS
    Am J Ind Med; 1997 Jul; 32(1):21-6. PubMed ID: 9131208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis.
    Maier LA; Sawyer RT; Tinkle SS; Kittle LA; Barker EA; Balkissoon R; Rose C; Newman LS
    Eur Respir J; 2001 Mar; 17(3):403-15. PubMed ID: 11405518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.
    Fontenot AP; Palmer BE; Sullivan AK; Joslin FG; Wilson CC; Maier LA; Newman LS; Kotzin BL
    J Clin Invest; 2005 Oct; 115(10):2886-93. PubMed ID: 16151531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
    Tinkle SS; Kittle LA; Newman LS
    J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium.
    Newman LS; Kreiss K
    Am Rev Respir Dis; 1992 May; 145(5):1212-4. PubMed ID: 1586067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.
    Mroz MM; Kreiss K; Lezotte DC; Campbell PA; Newman LS
    J Allergy Clin Immunol; 1991 Jul; 88(1):54-60. PubMed ID: 2071785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beryllium-stimulated apoptosis in macrophage cell lines.
    Sawyer RT; Fadok VA; Kittle LA; Maier LA; Newman LS
    Toxicology; 2000 Aug; 149(2-3):129-42. PubMed ID: 10967410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells.
    Saltini C; Winestock K; Kirby M; Pinkston P; Crystal RG
    N Engl J Med; 1989 Apr; 320(17):1103-9. PubMed ID: 2469014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory factors contributing to uninterpretable beryllium lymphocyte proliferation tests (BeLPT).
    Smith DE; Golden AP; Stange AW; Barker E; Mroz M; Barón AE; Ghosh D; Maier L; Cragle D; Newman LS
    Am J Ind Med; 2018 Jul; 61(7):592-604. PubMed ID: 29574954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.
    Tinkle SS; Newman LS
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1884-91. PubMed ID: 9412570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells.
    Amicosante M; Berretta F; Franchi A; Rogliani P; Dotti C; Losi M; Dweik R; Saltini C
    Eur Respir J; 2002 Nov; 20(5):1174-8. PubMed ID: 12449171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood testing for chronic beryllium disease.
    Kreiss K; Newman LS; Mroz M
    J Occup Med; 1991 Nov; 33(11):1188-9. PubMed ID: 1765863
    [No Abstract]   [Full Text] [Related]  

  • 16. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease.
    Fontenot AP; Kotzin BL; Comment CE; Newman LS
    Am J Respir Cell Mol Biol; 1998 Apr; 18(4):581-9. PubMed ID: 9533947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compartmentalized immune response reflects clinical severity of beryllium disease.
    Newman LS; Bobka C; Schumacher B; Daniloff E; Zhen B; Mroz MM; King TE
    Am J Respir Crit Care Med; 1994 Jul; 150(1):135-42. PubMed ID: 8025739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing BeLPT criteria for beryllium sensitization.
    Middleton DC; Fink J; Kowalski PJ; Lewin MD; Sinks T
    Am J Ind Med; 2008 Mar; 51(3):166-72. PubMed ID: 18181198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease.
    Tinkle SS; Schwitters PW; Newman LS
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):969-71. PubMed ID: 8933043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vivo and in vitro measures of beryllium sensitization.
    Bobka CA; Stewart LA; Engelken GJ; Golitz LE; Newman LS
    J Occup Environ Med; 1997 Jun; 39(6):540-7. PubMed ID: 9211212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.